Affiliation:
1. From the Masonic Medical Research Laboratory (S.S., A.B., C.A.), Utica, NY; and Gilead Sciences, Inc (L.B.), Palo Alto, Calif.
Abstract
Background—
Amiodarone and ranolazine have been characterized as inactivated- and activated-state blockers of cardiac sodium channel current (I
Na
), respectively, and shown to cause atrial-selective depression of I
Na
-related parameters. This study tests the hypothesis that their combined actions synergistically depress I
Na
-dependent parameters in atria but not ventricles.
Methods and Results—
The effects of acute ranolazine (5 to 10 μmol/L) were studied in coronary-perfused right atrial and left ventricular wedge preparations and superfused left atrial pulmonary vein sleeves isolated from chronic amiodarone-treated (40 mg/kg daily for 6 weeks) and untreated dogs. Floating and standard microelectrode techniques were used to record transmembrane action potentials. When studied separately, acute ranolazine and chronic amiodarone caused atrial-predominant depression of I
Na
-dependent parameters. Ranolazine produced a much greater reduction in V
max
and much greater increase in diastolic threshold of excitation and effective refractory period in atrial preparations isolated from amiodarone-treated versus untreated dogs, leading to a marked increase in postrepolarization refractoriness. The drug combination effectively suppressed triggered activity in pulmonary vein sleeves but produced relatively small changes in I
Na
-dependent parameters in the ventricle. Acetylcholine (0.5 μmol/L) and burst pacing induced atrial fibrillation in 100% of control atria, 75% of ranolazine-treated (5 μmol/L) atria, 16% of atria from amiodarone-treated dogs, and in 0% of atria from amiodarone-treated dogs exposed to 5 μmol/L ranolazine.
Conclusions—
The combination of chronic amiodarone and acute ranolazine produces a synergistic use-dependent depression of I
Na
-dependent parameters in isolated canine atria, leading to a potent effect of the drug combination to prevent the induction of atrial fibrillation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献